Engineered Nanoparticle Applications for Recombinant Influenza Vaccines.
Sign Up to like & getrecommendations! Published in 2020 at "Molecular pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.0c00383
Abstract: Influenza viruses cause seasonal epidemics and represent a pandemic risk. With current vaccines methods struggling to protect populations against emerging strains, there is demand for a next-generation flu vaccine capable of providing broad protection. Recombinant… read more here.
Keywords: influenza vaccines; nanoparticle; engineered nanoparticle; recombinant influenza ... See more keywords